Artificial Hearts Without Heartbeats

The interesting question regarding the removal of the human heartbeat is the impact it will have on other bodily systems. Will it extend life by reducing stress on, for example, vulnerable blood vessels in the brain, or will it shorten life by also eliminating the beneficial response to that stress? Researchers are making progress in artificial hearts, so this question will likely be answered at some point over the next few decades: "The search for the perfect artificial heart seems never-ending. After decades of trial and error, surgeons remain stymied in their quest for a machine that does not wear out, break down or cause clots and infections. But Dr. Billy Cohn and Dr. Bud Frazier at the Texas Heart Institute say they have developed a machine that could avoid all that with simple whirling rotors - which means people may soon get a heart that has no beat. Inside the institute's animal research laboratory is an 8-month-old calf with a soft brown coat named Abigail. Cohn and Frazier removed Abigail's heart and replaced it with two centrifugal pumps. ... If you listened to her chest with a stethoscope, you wouldn't hear a heartbeat. If you examined her arteries, there's no pulse. If you hooked her up to an EKG, she'd be flat-lined. ... The pumps spin Abigail's blood and move it through her body. ... The doctors say the continuous-flow pump should last longer than other artificial hearts and cause fewer problems. That's because each side has just one moving part: the constantly whirling rotor. But Cohn says they will still have to convince the world that you don't need a pulse to live. ... We look at all the animals, insects, fish, reptiles and certainly all mammals, and see a pulsatile circulation. And so all the early research and all the early efforts were directed at making pulsatile pumps. ... However, the only reason blood must be pumped rhythmically instead of continuously is the heart tissue itself. ... The pulsatility of the flow is essential for the heart, because it can only get nourishment in between heartbeats. If you remove that from the system, none of the other organs seem to care much."

Link: http://www.npr.org/2011/06/13/137029208/heart-with-no-beat-offers-hope-of-new-lease-on-life

Investigating the Graying of Hair

If the level of interest the public has in their gray hair could only be transferred to an interest in practical work to repair aging, how much better off we'd be. Here is more research into the biological causes of loss of hair pigmentation with aging: "Wnt signaling, already known to control many biological processes, between hair follicles and melanocyte stem cells can dictate hair pigmentation. ... We have known for decades that hair follicle stem cells and pigment-producing melanocycte cells collaborate to produce colored hair, but the underlying reasons were unknown. We discovered Wnt signaling is essential for coordinated actions of these two stem cell lineages and critical for hair pigmentation. ... The study suggests the manipulation of Wnt signaling may be a novel strategy for targeting pigmentation such as graying hair. The research study also illustrates a model for tissue regeneration. ... Using genetic mouse models, researchers were able to examine how Wnt signaling pathways enabled both hair follicle stem cells and melanocyte stem cells to work together to generate hair growth and produce hair color. Research also showed the depletion (or inhibition or abnormal) Wnt signaling in hair follicle stem cells not only inhibits hair re-growth but also prevents melanocytes stem cell activation required for producing hair color. The lack of Wnt activation in melanocyte stem cells leads to depigmented or gray hair."

Link: http://www.sciencedaily.com/releases/2011/06/110614115046.htm

Should We Treat Aging?

"Should we treat aging?" is a rhetorical question here, but sadly it remains a straightforward open question for much of the world - when it is asked, they are quite serious in asking it. People expect there to be good reasons as to why aging should be left as it is, the cause of death for more than 100,000 people each and every day, and scientists restrained from working on therapies of rejuvenation. This is one of the uphill struggles taking place in the patient advocacy community for aging research, that most people don't consider themselves patients exhibiting the symptoms of degenerative aging, have little inclination to do anything about it, and are in fact initially hostile to the whole idea.

Here's an American Scientist article from researcher David Gems that asks the rhetorical question in the title of this post, and answers it for those who don't see things the way we do:

I am a scientist working in the growing field of biogerontology - the biology of aging. The cause of aging remains one of the great unsolved scientific mysteries. Still, the past decade has brought real progress in our understanding, raising the prospect that treatments might one day be feasible. Yet aging is not just another disease. And the prospect of treating aging is extraordinary in terms of the potential impact on the human condition. So, would it be ethical to try to treat it?

...

I argue for the recognition of an imperative to seek treatments that decelerate aging in order to alleviate late-life diseases. But at what point would such an imperative be fulfilled? Although decelerating aging would postpone the illnesses of aging, it would not make them any less awful. This means that achieving decelerated aging would not lessen the imperative. We would only be compelled to decelerate aging further, and then further still. Here the ethical calculus seems to set us inexorably on a road to ever-greater life extension. Could any sane authority ever opt to force others to forego treatment and suffer from avoidable age-related disease? Surely not.

So it is that decelerated aging would force a dilemma upon us. Should we alleviate suffering on a large scale and accept life extension? Or should we allow an immensity of avoidable suffering in order to avoid extending life? To my mind, the only reasonable course is the first. In fact, we should pursue it energetically, and begin to prevent illness as soon as is feasible. If not, we risk the fury of future generations for dithering. As for life extension, we will just have to take that on the chin. If we can prepare for it socially, politically and institutionally, and if we keep birth rates low, we should be able to ensure long, healthier, happier lives for our children and for our children's children.

In reading this, one must understand there there are a great many people in the world whose first, instinctive reaction to extending healthy human life is to reject it. For them, life extension is indeed a bad thing. Various strains of environmentalism are one of the main culprits here: so many minds are poisoned by the false ideas that spread from environmentalist and related Malthusian ideologies: that there are too many people, that people are intrinsically bad, that wealth and longevity are intrinsically bad, that economics is a zero-sum game, and so forth.

There's nothing wrong with liking trees and wild places enough to spend your hard-earned resources on helping to maintain them. But environmentalism has a way of veering off into the worship of death and destruction, a sort of modern penitent movement focused on the mortification of society as a whole. It's so widespread and embedded in our cultures now that even mild-mannered, everyday folk declare their support for shorter and fewer human lives, for abandonment of technologies that improve the quality of human life, and for relinquishment of technological development that will greatly improve life in the future.

In the long run, these are the ideas we must defeat and bury if we are to build the level of understanding and support required to speed the advent of rejuvenation biotechnology.

Meat industry lying about E. coli contamination

The meat industry has been misusing data to make it appear that E. coli contamination of meat is decreasing, said Barbara Kowalcyk of the Center for Foodborne Illness, Research and Prevention.

Executives from the American Meat Institute (AMI) have claimed success in the beef industry's efforts to reduce contamination with the dangerous E. coli strain O157:H7. According to the AMI, inspection data from the U.S. Department of Agriculture's (USDA's) Food Safety and Inspection Service show a 45 percent drop in E. coli prevalence between 2000 and 2008.

Yet Kowalcyk calls this is a misuse of data never intended for "year-to-year comparisons."

"USDA's E. coli ... testing program is strictly regulatory and was not statistically designed to estimate the prevalence of E. coli O157:H7 in raw ground beef," she said.

Although a 45 percent drop is in fact found in the data, Kowalcyk notes that different facilities were tested and different testing methods used each year. She called the AMI's conclusion as valid as comparing a person who weighed 300 pounds in 2000 to a different person weighing 150 pounds in 2008, then concluding that the average weight of the U.S. population had dropped 50 percent. Read more...

Ayurtox for Body Detoxification

A New Look at Obsessive-Compulsive Disorder (preview)

One day 12-year-old Elizabeth McIngvale became obsessed with the number 42, which happened to be her mother’s age at the time, 11 years ago. When she washed her hands, she had to turn the sink on and off 42 times, get 42 pumps of soap and rinse her hands 42 times. Sometimes she decided that she actually needed to do 42 sets of 42. When she dressed, she put her right leg in and out of her pant leg 42 times, then the left. Even getting up from a chair took 42 attempts. She was afraid that if she did not follow her self-prescribed ritual, something terrible would happen to her family--they might die in a car accident, for instance. “Everything I did was completely exhausting and grueling,” she recalls. “I was probably doing 12 to 13 hours a day of rituals.”

McIngvale was diagnosed with obsessive- compulsive disorder (OCD), a psychiatric illness that afflicts 2 to 3 percent of Americans, not all of them as severely as McIngvale. Individuals with OCD experience debilitating recurrent and persistent thoughts, or obsessions, which they try to suppress or eliminate with rituals, known as compulsions. Compared with people who have other anxiety or mood disorders, adults with OCD are more likely to be single and unemployed. In fact, OCD is among the 10 most disabling medical and psychiatric conditions.

[More]

Add to digg
Add to StumbleUpon
Add to Reddit
Add to Facebook
Add to del.icio.us
Email this Article


Autism’s Tangled Genetics Full of Rare and Varied Mutations

The underpinnings of autism are turning out to be even more varied than the disease's diverse manifestations. In four new studies and an analysis published June 8 researchers have added some major landmarks in the complex landscape of the disease, uncovering clues as to why the disease is so much more prevalent in male children and how such varied genetic mutations can lead to similar symptoms. [More]

Add to digg
Add to StumbleUpon
Add to Reddit
Add to Facebook
Add to del.icio.us
Email this Article


Autism's Tangled Genetics Full of Rare and Varied Mutations

The underpinnings of autism are turning out to be even more varied than the disease's diverse manifestations. In four new studies and an analysis published June 8 researchers have added some major landmarks in the complex landscape of the disease, uncovering clues as to why the disease is so much more prevalent in male children and how such varied genetic mutations can lead to similar symptoms. [More]

Add to digg
Add to StumbleUpon
Add to Reddit
Add to Facebook
Add to del.icio.us
Email this Article


International Stem Cell Corporation (ISCO) Announces That Donna Queen, Former President and CEO of ZO SKIN HEALTH, the Luxury Brand Created by Zein Obagi, MD, Has Joined ISCO Executive Team

International Stem Cell Corporation (OTCBB:ISCOE) announced today that Donna Queen has joined ISCO's executive team. Ms. Queen will be primarily responsible for ISCO's wholly owned subsidiary Lifeline Skin Care's (Lifeline) brand identity and international marketing as well as broadening the range of Lifeline products currently available.


Prior to joining ISCO, Ms. Queen was President and CEO of ZO SKIN HEALTH® by Zein Obagi, MD. Dr. Obagi is the dermatologist who created the original Obagi Nu-Derm skincare system, which has since become the leading physician-dispensed brand of anti-aging skincare. Earlier Ms. Queen founded and led one of Virginia's largest advertising and marketing agencies, specializing in aesthetic and dermatological marketing and brand development.


Dr. Andrey Semechkin, President and CEO of ISCO, commented: "I'm very pleased that Ms. Queen has joined our team. Ms. Queen's industry experience and expertise particularly in marketing prescription-based products will be invaluable as we expand our skin care business and further enhance our line of products."


Ms. Queen adds, "I'm very excited to be joining such a dynamic, science-driven company. There have been no recent meaningful technological breakthroughs in skin care, but with ISCO's scientific leadership in stem cells and their knowledge of skin tissue physiology we have an opportunity to continue to deliver new and innovative treatments."


ISCO previously announced sales of approximately $1.1 million from the pilot direct-to-consumer launch of Lifeline's first two products, an anti-aging Day Serum and a Night Serum. These products were developed by ISCO's scientific research team in collaboration with internationally recognized cosmetics experts. The serums contain an extract from ISCO?s proprietary human parthenogenetic stem cells combined with antioxidants and botanically derived ingredients. Using these serums on a regular basis provides significant benefits to the skin including improvement in skin tone and elasticity and the improvement in the appearance of fine lines and wrinkles, results that have been independently established by clinical studies performed at industry-leading testing laboratories. The serums can be purchased by visiting Lifeline?s website at http://www.lifelineskincare.com and are also available at selected luxury spas and physicians' offices in the United States.


About International Stem Cell Corporation
International Stem Cell Corporation is focused on the therapeutic applications of human parthenogenetic stem cells and the development and commercialization of cell-based research and cosmetic products. ISCO's core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs). hpSCs avoid ethical issues associated with the use or destruction of viable human embryos. ISCO scientists have created the first parthenogenic, homozygous stem cell line that can be a source of therapeutic cells with minimal immune rejection after transplantation into hundreds of millions of individuals of differing genders, ages and racial background. This offers the potential to create the first true stem cell bank, UniStemCell™. ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide through its subsidiary Lifeline Cell Technology, and cell-based skin care products through its subsidiary Lifeline Skin Care. More information is available at http://www.internationalstemcell.com.


To subscribe to receive ongoing corporate communications, please click on the following link:http://www.b2i.us/irpass.asp?BzID=1468&to=ea&s=0.


Forward-looking Statements
Statements pertaining to anticipated developments, product development and marketing plans, and other opportunities for the company and its subsidiaries, along with other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements. Any statements that are not historical fact (including, but not limited to statements that contain words such as "will," "believes," "plans," "anticipates," "expects," "estimates,") should also be considered to be forward-looking statements. Forward-looking statements involve risks and uncertainties, including, without limitation, risks inherent in the development and/or commercialization of potential products, competition, regulatory approvals, need and ability to obtain future capital, application of capital resources among competing uses, and maintenance of intellectual property rights. Actual results may differ materially from the results anticipated in these forward-looking statements and as such should be evaluated together with the many uncertainties that affect the company's business, particularly those mentioned in the cautionary statements found in the company's Securities and Exchange Commission filings. The company disclaims any intent or obligation to update forward-looking statements.


http://cts.businesswire.com/ct/CT?id=bwnews&sty=20110616005464r1&sid=14230&distro=ftp
International Stem Cell Corporation
760-940-6383
Ruslan Semechkin, PhD
Vice President, ISCO
CEO, Lifeline Skin Care
ras@intlstemcell.com

or
Simon Craw, PhD
Vice President, ISCO
sc@intlstemcell.com
or
Lippert/Heilshorn & Associates
Don Markley
310-691-7100
dmarkley@lhai.com

International Stem Cell to Present at the Lippert/Heilshorn Life Sciences & Medtech Virtual Conference on June 16


International Stem Cell Corporation (OTCBB:ISCOE) announced today that Kenneth Aldrich, Chairman, will present to investors as part of the Lippert/Heilshorn & Associates Life Sciences & Medical Technologies Virtual Conference on Thursday, June 16, 2011 at 10:30 a.m. Eastern.

A webcast of the presentation will be accessible online at http://www.internationalstemcell.com, or the PrecisionIR event site: http://www.vcall.com/CustomEvent/lipper/index.aspAn archived version will be available for 30 days.

About International Stem Cell Corporation
International Stem Cell Corporation is focused on the therapeutic applications of human parthenogenetic stem cells and the development and commercialization of cell-based research and cosmetic products. ISCO's core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs). hpSCs avoid ethical issues associated with the use or destruction of viable human embryos. ISCO scientists have created the first parthenogenic, homozygous stem cell line that can be a source of therapeutic cells with minimal immune rejection after transplantation into hundreds of millions of individuals of differing genders, ages and racial background. This offers the potential to create the first true stem cell bank, UniStemCell™. ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide through its subsidiary Lifeline Cell Technology, and cell-based skin care products through its subsidiary Lifeline Skin Care. More information is available at http://www.internationalstemcell.com.

To subscribe to receive ongoing corporate communications, please click on the following link:http://www.b2i.us/irpass.asp?BzID=1468&to=ea&s=0.

International Stem Cell Corporation
Kenneth C Aldrich, Chairman
760-940-6383
kaldrich@intlstemcell.com

or
Lippert/Heilshorn & Associates
Don Markley
310-691-7100
dmarkley@lhai.com

International Stem Cell to Present at the Lippert/Heilshorn Life Sciences & Medtech Virtual Conference on June 16


International Stem Cell Corporation (OTCBB:ISCOE) announced today that Kenneth Aldrich, Chairman, will present to investors as part of the Lippert/Heilshorn & Associates Life Sciences & Medical Technologies Virtual Conference on Thursday, June 16, 2011 at 10:30 a.m. Eastern.

A webcast of the presentation will be accessible online at http://www.internationalstemcell.com, or the PrecisionIR event site: http://www.vcall.com/CustomEvent/lipper/index.aspAn archived version will be available for 30 days.

About International Stem Cell Corporation
International Stem Cell Corporation is focused on the therapeutic applications of human parthenogenetic stem cells and the development and commercialization of cell-based research and cosmetic products. ISCO's core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs). hpSCs avoid ethical issues associated with the use or destruction of viable human embryos. ISCO scientists have created the first parthenogenic, homozygous stem cell line that can be a source of therapeutic cells with minimal immune rejection after transplantation into hundreds of millions of individuals of differing genders, ages and racial background. This offers the potential to create the first true stem cell bank, UniStemCell™. ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide through its subsidiary Lifeline Cell Technology, and cell-based skin care products through its subsidiary Lifeline Skin Care. More information is available at http://www.internationalstemcell.com.

To subscribe to receive ongoing corporate communications, please click on the following link:http://www.b2i.us/irpass.asp?BzID=1468&to=ea&s=0.

International Stem Cell Corporation
Kenneth C Aldrich, Chairman
760-940-6383
kaldrich@intlstemcell.com

or
Lippert/Heilshorn & Associates
Don Markley
310-691-7100
dmarkley@lhai.com

Drug companies trying to "create" parasites for treating ulcerative colitis

Ulcerative colitis, a type of inflammatory bowel disease (IBD), is less common in countries endemic for helminth infections, suggesting that helminth colonization may have the potential to regulate intestinal inflammation in IBD. Therapeutic effects of experimental helminth infection have been reported.

According to a researcher: "What we found was that after worm infection, the regions of the colon that were previously not making mucus, were now making mucus again."

"That's a key factor in healing, and it looked like the mucus came back because the worms were causing the body to produce IL-22. This is a molecule that promotes epithelial growth and healing."
Studies suggest parasites can regulate the immune system in ways that prevent it from "going wild" and attacking healthy tissue, and possibly human evolution took that into account.

A case report in the journal Science Translational Medicine provides a cellular and molecular portrait of dynamic changes in the intestinal mucosa of an individual who infected himself with Trichuris trichiura to treat his symptoms of ulcerative colitis.

Tissue with active colitis had a prominent population of mucosal T helper (TH) cells that produced the inflammatory cytokine interleukin-17 (IL-17) but not IL-22, a cytokine involved in mucosal healing.

After helminth exposure, the disease went into remission, and IL-22–producing TH cells accumulated in the mucosa. Genes involved in carbohydrate and lipid metabolism were up-regulated in helminth-colonized tissue, whereas tissues with active colitis showed up-regulation of proinflammatory genes such as IL-17, IL-13RA2, and CHI3L1.

T. trichiura colonization of the intestine may reduce symptomatic colitis by promoting goblet cell hyperplasia and mucus production through TH2 cytokines and IL-22. Controlled helminth infections may lead to new therapies for inflammatory bowel diseases.

References:

Eat Your Worms: The Upside Of Parasites. NPR.

M. J. Broadhurst, J. M. Leung, V. Kashyap, J. M. McCune, U. Mahadevan, J. H. McKerrow, P. Loke, IL-22+ CD4+ T Cells Are Associated with Therapeutic Trichuris trichiura Infection in an Ulcerative Colitis Patient. Sci. Transl. Med. 2, 60ra88 (2010).

Image source: Trichuris egg in stool sample (40x). Wikipedia, GNU Free Documentation License, Version 1.2.

Posted at Clinical Cases and Images. Stay updated and subscribe, follow us on Twitter and connect on Facebook.


Memorable medical textbooks of the past

Medical textbooks were not always as dreary and as bland as they are now, according to BMJ. Some examples of lively, first person didactic tone come from J L Burton’s Essentials of Dermatology:

"The Lord Privy Seal is neither a lord, nor a privy, nor a seal" and "‘seborrhoeic’ warts have no relationship to seborrhoea."

"The simultaneous occurrence of scabies in a doctor and a nurse may mean that they have shared nothing more exciting than a patient with Norwegian scabies."

Explanation:
The Lord Privy Seal (or, more formally, the Lord Keeper of the Privy Seal) is the fifth of the Great Officers of State in the United Kingdom. Originally, its holder was responsible for the monarch's personal (privy) seal (as opposed to the Great Seal of the Realm). Though one of the oldest offices in government anywhere, it has no particular function today.
Seborrhoeic keratosis (seborrhoeic wart, basal cell papilloma) is a benign overgrowth of the basal cells of the epidermis. The patient is usually elderly and concerned because the lesion is unsightly.

References:

Image source: Seborrheic keratosis, Wikipedia, GNU Free Documentation License, Version 1.2.

Posted at Clinical Cases and Images. Stay updated and subscribe, follow us on Twitter and connect on Facebook.


A microscopic look at hotel hygiene makes a microbiologist travel with an impervious mattress cover

From CNN:

The microbiologist Philip Tierno doesn't feel comfortable staying in hotels. He knows too much. He travels with an impervious mattress and pillow cover to protect against the unseen debris that guests leave behind. When humans sleep they shed about 1.5 million cells an hour.

While the covers were developed for allergy sufferers, Tierno encourages everyone to use them at home and on the road.

And definitely ditch the bedspread, he advises. Hotel bedspreads became a hot topic when one featuring bodily fluids from several sources was introduced in boxer Mike Tyson's 1992 rape trial.

How hotels clean drinking glasses

An Atlanta TV station used hidden cameras to monitor how the drinking glasses in hotel rooms were cleaned. In one case, a housekeeper appeared to clean a toilet and the glasses wearing the same gloves. In multiple hotels, the glasses were rinsed in the sink and dried for the next guests, in violation of health codes.

The Health Magazine lists the 12 germiest places in America or the so called "dirty dozen":

  1. Kitchen sink
  2. Airplane bathroom
  3. A load of wet laundry
  4. Public drinking fountain
  5. Shopping cart handle
  6. ATM buttons
  7. Playgrounds
  8. Bathtub
  9. Office phone
  10. Hotel-room remote

References:
A microscopic look at hotel hygiene, CNN, 2011.

Posted at Clinical Cases and Images. Stay updated and subscribe, follow us on Twitter and connect on Facebook.


Sleep Habits Differ by Ethnicity but All Groups Are Sleep Deprived

All ethnic groups said they missed work or family functions because they were too sleepy, with the percentage ranging up to 24%, according to a 2010 "Sleep in America" survey by the National Sleep Foundation (NSF).

Some distinct differences are listed below:

On weekdays or workdays, African Americans reported they slept the least - 6 hours, 14 minutes, compared to 6 hours, 34 minutes for Hispanics, 6 hours, 48 minutes for Asians, and 6 hours, 52 minutes for Caucasians.

10% of African Americans and Hispanics reported having sex every night or nearly every night in the hour before bedtime, compared to 4% of Caucasians and 1% of Asians.

African Americans had different pre-bedtime activities and tended to pray in the hour before bedtime - 71% of them said they prayed but only 18% of Asians did so.

Asians were least likely to drink alcohol an hour before bed - a practice that many mistakenly think will help sleep. Only 1% of Asians had a nightcap every night or nearly every night, compared to 7% of whites, 4% of African Americans and Hispanics.

Caucasians were most likely to sleep with their pets - as well as more likely to sleep with their spouse or significant others: 16% of them say they sleep with a pet, and 72% say they sleep with their partners. In comparison, only 4% of Asians, 4% of Hispanics, and 2% of African Americans let the pet on the bed.

References:

The 2010 Sleep in America poll by the National Sleep Foundation (NSF).
Image source: A halo around the Moon. Wikipedia, GNU Free Documentation License.

Posted at Clinical Cases and Images. Stay updated and subscribe, follow us on Twitter and connect on Facebook.


Acyclovir reduces risk of HIV-1 disease progression, if positive for HIV-1 and HSV-2

Most people infected with HIV-1 are dually infected with herpes simplex virus type 2. Daily suppression of this herpes virus reduces plasma HIV-1 concentrations, but whether it delays HIV-1 disease progression is unknown.

In this study, the median CD4 cell count at enrollment was 462 cells per ?L and median HIV-1 plasma RNA was 4 log10 copies per ?L. Aciclovir reduced risk of HIV-1 disease progression by 16%.

The role of suppression of herpes simplex virus type 2 in reduction of HIV-1 disease progression before initiation of antiretroviral therapy warrants consideration.

References:

Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial. The Lancet, Volume 375, Issue 9717, Pages 824 - 833, 6 March 2010.
Image source: Diagram of HIV. Image source: Wikipedia.

Posted at Clinical Cases and Images. Stay updated and subscribe, follow us on Twitter and connect on Facebook.


Google Apps Scripts for an intuitive interface to organic chemistry Open Notebooks

Rich Apodaca recently demonstrated how Google Apps Scripts can be added to Google Spreadsheets to enable simple calling of web services for chemistry applications (gChem). Although we have been using web service calls from within a Google spreadsheet for some time (solubility calculation by NMR link #3 and misc chem conversions link #1), the process wasn't as intuitive as it could be because one had to find then paste lengthy urls.

Rich's approach enables simply clicking the desired web service from a menu on Google Spreadsheets and these functions have simple names like getSMILES. Andrew Lang has now added several web services from our ONS projects and the CDK. There are now 3 menus to choose from: gChem, gCDK and gONS.


To demonstrate the power of these tools consider the rapid construction of a customized interface to an experiment in a lab notebook (in this example UC-EXP263).

1) Because Andy has added a gONS service to render images of molecules from ChemSpider, consistent reaction schemes can now be constructed from this template by simply typing the name of the reactants and products then embedding in the wiki.

2) Planning of the reaction to calculate reactant amounts and product yield can then be processed by simply typing the name of the chemicals. Services calling molecular weight and density are automatic based on the chemical name as input.


3) Typing the name of the solvent then allows easy access to the solubility properties of the reaction components. The calculated concentrations of the reactants and product can be directly compared with their measured maximum solubility. In this experiment the observed separation of the product from the solution is consistent with these measurements.

4) Both experimental and predicted melting points (using Model002) can then be lined up for comparison. A large discrepancy between the two would flag a possible error - in this case good agreement is found. Noting that the product's melting point is near room temperature (53 C) explains why two layers were were observed to form during the course of the reaction and cooling to 0 C induced the product to precipitate. Links to the melting measurements are also provided in column N for easy exploration.

5) Column O provides a quick link to the ChemSpider entries for all compounds and column P provides links to the Reaction Attempts Explorer where, for example, one can explore other reactions where the product was involved. Finally columns Q and R provide one click access to an interactive NMR spectrum of the product, powered by ChemDoodle.

The last few columns still use our older code to call web services but over time these should be added to the gONS collection for convenience.

The easiest way to experiment with this interface is probably to just make a copy (File -> Make a Copy from the Google Spreadsheet menu). The sheet can then be customized for other applications.

Live Tweeting Haumea: the Open Science Ratchet at work?

Eugenie Samuel Reich just announced on the Nature NewsBlog that astronomer Mike Brown live-tweeted his observations of a transit of dwarf planet Haumea by its moon, Namaka.

About a year ago, I wrote about Mike Brown and the controversy about the discovery of Haumea stemming from a competitor's more aggressive data dissemination practice. In that post I speculated that we could expect accelerated data sharing over time due to the Open Science Ratchet, where the actions of scientists that are most open set the pace for everyone else working on that particular project, regardless of their views on how secretive science should be.

I don't know if Mike Brown has changed his views on data sharing - or if he has always felt this way but thought it was too risky until now. Either way, he certainly is taking the lead at this point to demonstrate how radical openness can be done in astronomy!

My talk at SLA on Trust in Science and Open Melting Point Collections

On June 14 and 15, 2011 I attended the Special Libraries Association conference and made presentations on two panels on the role of trust in science with a case-study of the Open Melting Point collections that Andrew Lang, Antony Williams and I have been assembling and curating.

The first panel was on the "International Year of Chemistry: Perils and Promises of Modern Communication in the Sciences". My colleague Laurence Souder from the Department of Culture and Communications at Drexel presented on "Trust in Science and Science by Blogging", using as an example the NASA press release on arsenic replacing phosphorus in bacteria and subsequent controversy taking place in the blogosphere. (see post in Scientific American blog today)

Watch Lawrence Souder's presentation screencast and slides.

The second panel was on "New Forms of Scholarly Communications in the Sciences". Don Hagen from the National Technical Information Service presented on "NTIS Focus on Science and Data: Open and Sustainable Models for Science Information Discovery" and Dorothea Salo discussed the evolving role of libraries and institutional repositories on scholarly communication and archiving.

Watch Don Hagen's presentation screencast and slides.

My own slides and screencast from the second panel are available below:

The Skeletal Man

Marco sent in this video, produced by Jeff Lowe, that showcases the 4 hours of outlineing and 6 hours of shading to create an entire skeleton on his back. Fascinating.